NEOCUTIS® RECEIVES ITS 16th INSTYLE “BEST BEAUTY BUY” AWARD. Lumière® Recognized by InStyle as “Best Eye Cream”
Merz Aesthetics, a division of Merz North America, announced today that NEOCUTIS® Lumière was named an InStyle 2017 “Best Beauty Buy” award winner for “Best Eye Cream.” Each year the publication polls the industry’s top experts to identify the best performing beauty products. This year’s winners are featured in the May 2017 issue of InStyle.
“I have always considered NEOCUTIS® Lumière to be a leader in the eye cream category because of its innovative formula and proven results,” said Dr. Ulysses Scarpidis, board-certified plastic surgeon at Scarpidis Aesthetics in New York, NY. “Its formula is packed with a powerful blend of energizing and moisturizing ingredients to give the eye area a younger, more refreshed look. My patients that use it have never looked back.”
This year’s InStyle award marks the 16th time that NEOCUTIS® has been awarded a “Best Beauty Buy” title since 2009. Of those 16 award wins, Lumière has been honored as an InStyle “Best Beauty Buy” nine years in a row, with a total of 11 award wins.
“We are thrilled to celebrate yet another InStyle award win for NEOCUTIS® Lumière,” said Jim Hartman, Vice President and US Head of Merz Aesthetics and OTC Marketing. “The continued recognition is a true testament to the cutting-edge scientific research and technology that goes into the NEOCUTIS® formulas, that are both industry and physician approved.”
NEOCUTIS® Lumière is infused with PSP® (Processed Skin Proteins) – the brand’s patented, anti-aging technology. This exclusive technology is an optimally balanced blend of proteins, including human growth factors, that support your skin’s natural processes to preserve healthy, youthful-looking skin.
NEOCUTIS® products are available for purchase exclusively through medical practices and skincare providers. For additional information, or to find an www.MerzUSA.com authorized NEOCUTIS® Skincare provider near you, please visit www.NEOCUTIS.com.
About Merz Aesthetics
Merz Aesthetics is a division of Merz North America and offers a wide-ranging portfolio of treatment options including Device (Ultherapy®, CellfinaTM System, DESCRIBE® PFD Patch), Injectables (Xeomin®, Radiesse® Volumizing Filler, Belotero Balance®, Asclera®) and Skincare (NEOCUTIS®, Mederma®) that enable physicians to meet the needs of a broad range of patients and their skin concerns. To learn more about Merz Aesthetics, please visit www.merzusa.com/aesthetics- otc.
About Merz North America
Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Merz North America is a privately-held company based in Raleigh, North Carolina. To learn more about Merz North America, please visit www.merzusa.com.
Corporate Communications Merz North America
6501 Six Forks Road Raleigh, NC 27615
Office (919) 582-8114
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
Merz North America